• Conflicts of Interest, Authorship, and Disclosures in Industry-Related Scientific Publications — Mayo Clinic Proceedings – We read with great interest the recent article by Hirsch1 and the accompanying editorial and appreciate that a venue for rational discourse has been opened. Recently, we have all witnessed increasing scrutiny and regulation of the relationship we, as clinical educators and investigators, have with our partners in industry and the continuing medical education (CME) providers with whom we work. What has been missing from this important dialogue is a concerted response from those who have worked with the pharmaceutical industry and providers of CME to present the opinion that these interactions are in fact of real value.
• Digital Pharma: Amgen’s online village | InPharm – Amgen has launched an online community for European healthcare professionals, patients and carers affected by autoimmune disease immune thrombycytopenia.

Related posts:

1. CME: New Online Performance Improvement Programs for Physicians
2. Pharma and Social Media; Gaming against Cancer; Evidence for Online Education
3. e-Health Game Changers: Smart phones, social media, and popular online groups
4. Online Support Groups, Diabetes and Twitter, and “Facebook for Pharmacists”
5. GroupLoop.org: Free Online Support and Social Networking Community for Teens with Cancer and Their Parents

Tags: CME, health 2.0, social media, thrombycytopenia

This entry was posted on Tuesday, June 29th, 2010 at 9:05 am and is filed under CME, health 2.0. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.